Age-dependent decline of dopamine D1 receptors in human brain: A PET study

Synapse

Volumn 30, Issue 1, 1998, Pages 56-61

  Wang, Yue ^a   Chan, Grace L Y ^a   Holden, James E ^b   Dobko, Teresa ^a   Mak, Edwin ^a   Schulzer, Michael ^a   Huser, Joseph M ^a   Snow, Barry J ^a   Ruth, Thomas J ^a   Calne, Donald B ^a   Stoessl, A Jon ^a,c  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Ageing; D1 receptors; Dopamine; Positron emission tomography (PET)

Indexed keywords

DOPAMINE 1 RECEPTOR;

ADULT; AGED; AGING; ARTICLE; CAUDATE NUCLEUS; CORRELATION FUNCTION; EXTRAPYRAMIDAL SYNDROME; FEMALE; HUMAN; LIGAND BINDING; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING; RECEPTOR DENSITY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ADULT; AGED; AGING; BRAIN; CARBON RADIOISOTOPES; CAUDATE NUCLEUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; OCCIPITAL LOBE; PSYCHOMOTOR PERFORMANCE; PUTAMEN; RECEPTORS, DOPAMINE D1; REGRESSION ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 7344248553     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199809)30:1<56::AID-SYN7>3.0.CO;2-J     Document Type: Article

References (52)

1. 2) receptors. Eur. J. Pharmacol. 129:367-370.
2. Bugiani, O., Salvarini, S., Perdelli, F., Mancardi, G.L., Leonardi, A. (1978) Nerve cell loss with aging in the putamen. Eur. Neurol. 17:286-291.
3. Chan, G.L.-Y., Holden, J.E., Stoessl, A.J., Doudet, D.J., Dobko, T., Huser, J.M., Wang, Y., Morrison, K.S., English, C., Legg, B., Ruth, T.J. (1998) Reproducibility of [11C]SCH 23390 positron emission tomography in normal human subjects. J Nucl Med. 39:792-797.
4. Cordes, M., Snow, B.J., Cooper, S., Schulzer, M., Pate, B.D., Ruth, T.J., Calne, D.B. (1994) Age-dependent decline of nigrostriatal dopaminergic function: A positron emission tomographic study of grandparents and their children. Ann Neurol 36:667-670.
5. Cortes, R., Gueye, B., Pazos, A., Probst, A., Palacios, J.M. (1989) Dopamine receptors in human brain: autoradiographic distribution of D1 sites. Neuroscience 28:263-273.
6. De Keyser, J., Claeys, A., De Backer, J.P., Ebinger, G., Roels, F., Vauquelin, G. (1988) Autoradiographic localization of D1 and D2 dopamine receptors in the human brain. Neurosci Lett 91:142-147.
7. De Keyser, J., Ebinger, G., Vauquelin, G. (1989) Evidence for a widespread dopaminergic innervation of the human cerebral neocortex. Neurosci Lett 104:281-285.
8. De Keyser, J., De Backer, J.P., Vauquelin, G., Ebinger, G. (1990) The effect of aging on the D1 dopamine receptors in human frontal cortex. Brain Res 528:308-310.
9. De Keyser, J., De Backer, J.P., Vauquelin, G., Ebinger, G. (1991) D1 and D2 dopamine receptors in human substantia nigra: Localization and the effect of aging. J Neurochem 56:1130-1133.
10. Descarries, L., Lemay, B., Doucet, G., Berger, B. (1987) Regional and laminar density of the dopamine innervation in adult rat cerebral cortex. Neuroscience 21:807-824.
11. Duvoisin, R.C. (1971) The evaluation of extrapyramidal disease. In: Monoamines Noyaus Gris Centraux et Syndrome de Parkinson. J. de Ajuriaguerra and G. Gauthier, eds. Geneva: Georg and Cie SA, pp 313-325.
12. Farde, L. (1992) Selective D1- and D2-dopamine receptor blockade both induces akathisia in human - A PET study with [11C]SCH 23390 and [11C]raclopride. Psychopharmacology (Berlin) 107: 23-29.
13. Farde, L., Wiesel, F-A., Nordstrom, A.L., Sedvall, G. (1989) D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology (Berlin) 99: 28-31.
14. Fearnley, J.M., Lees, A.J. (1991) Ageing and Parkinson's disease: Substantia nigra regional selectivity. Brain 114:2283-2301.
15. Gerfen, C.R., Engber, T.M., Mahan, L.C., Susel, Z., Chase, T.N., Monsma, F.J.J., Sibley, D.R. (1990) D1/D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429-1432.
16. Giorgi, O., De Montis, G., Porceddu, M.L., Mele, S., Calderini, G., Toffano, G., Biggio, G. (1987) Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striaturn. Dev. Brain Res. 432:283-290.
17. Hietanen, M., Teravainen, H., Tsui, J.K., McLennan, D., Calne, D.B. (1987) The pegboard as a measurement of parkinsonisn deficit. Neurology [Suppl.] 37:266 [abrstract].
18. Hyttel, J. (1983) SCH23390 - The first selective dopamine D1 antagonist. Eur. J. Pharmacol. 91:153-154.
19. Hyttel, J. (1989) Parallel decrease in the density of dopamine D1 and D2 receptors in the corpus striatum of rats from 3 to 25 months of age. Pharmacol. Toxicol. 64:55-57.
20. Iorio, L.C., Barnett, A., Leitz, F.H., Houser, V.P., Korduba, A. (1983) SCH 23390, a potential benzazepine antipsychotic with unique interations on dopaminergic systems. J. Pharmacol. Exp. Ther. 226:462-468.
21. Karlsson, P., Farde, L., Halldin, C., Sedvall, G., Ynddal, L., Sloth-Neielsen, M. (1995) Oral administration of NNC 756 - A placebo controlled PET study of D1-dopmine receptor occupancy and pharmacodynamics in man. Psychopharmacology (Berlin) 119:1-8.
22. Kebabian, J.W., Calne, D.B. (1979) Multiple receptors for dopamine. Nature 277:93-96.
23. Kish, S.J., Shannak, K., Rajput, A., Deck, J.H.N., Hornykiewicz, O. (1992) Aging produces a specific pattern of striatal dopamine loss: Implications for the etiology of idiopathic Parkinson's disease. J. Neurochem. 58:642-648.
24. Logan, J., Fowler, J.S., Volkow, N.D., Wang, G.-J., Ding, Y.-S., Alexoff, D.L. (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 16:834-840.
25. Martin, W.R., Palmer, M.R., Patlak, C.S., Calne, D.B. (1989) Nigrastriatal function in humans studied with positron emission tomography. Ann. Neurol. 26:535-542.
26. McGeer, P.L., McGeer, E.G., Suzuki, J.S. (1977) Aging and extrapyramidal function. Arch. Neurol. 34:33-35.
27. Morgan, D.G., Finch, C.E. (1988) Dopaminergic changes in the basal ganglia. A generalized phenomenon of aging in mammals. Ann. N.Y. Acad. Sci. 515:145-160.
28. Morgan, D.G., Marcusson, J.O., Nyberg, P., Wester, P., Winblad, B., Goren, M.N., Finch, C.E. (1987) Divergent changes in D-1 and D-2 dopamine binding sites in human brain during aging. Neurobiol. Aging 8:195-201.
29. Mortimer, J.A. (1988) Human motor behavior and aging. Ann. N.Y. Acad. Sci. 515:54-66.
30. Murray, A.M., Waddington, J.L. (1991) Age-related changes in the regulation of behavior by D-1:D-2 dopamine receptor interactions. Neurobiol. Aging 12:431-435.
31. O'Boyle, K.M., Waddington, J.L. (1984) Loss of rat striatal dopamine receptors with aging is selective for D-2 but not D-1 sites: Association with increased non-specific binding of the D-1 ligand [3H]piflutixol. Eur. J. Pharmacol. 105:171-174.
32. 11C]Sch23390). Appl. Radiat. Isot. 38:305-306.
33. Raz, N., Torres, I.J., Acker, J.D. (1995) Age, gender, and hemispheric differences in human striatum: a quantitative review and new data from in vivo MRI morphometry. Neurobiol. Learning Memory 63:133-142.
34. Ricci, A., Zaccheo, D., Amenta, F. (1995) Identification of age-related changes of dopamine D1-like receptors in the rat cerebellar cortex. Synapse 21:37-44.
35. Richfield, E.K., Debowey, D.L., Penney, J.B., Young, A.B. (1987) Basal ganglia and cerebral cortical distribution of dopamine D1- and D2-receptors in neonatal and adult cat brain. Neurosci. Lett. 73:203-208.
36. Rinne, J.O. (1987) Muscarinic and dopaminergic receptors in the aging human brain. Brain Res. 404:162-168.
37. Rinne, J.O., Lonnberg, P., Marjamaki, P. (1990) Age-dependent decline in human brain dopamine D1 and D2 receptors. Brain Res. 508:349-352.
38. Roth, R.S., Hess, G.D. (1982) Changes in the mechanisms of hormone and neurotransmitter action during aging: Current status of the role of receptor and post-receptor alterations. A review. Mech. Ageing Dev. 20:175-194.
39. Scherman, D., Desnos, C., Darchen, F., Pollak, P., Javoy-Agid, F., Agid, Y. (1989) Striatal dopamine deficiency in Parkinson's disease: Role of aging. Ann. Neurol. 26:551-557.
40. Sedvall, G., Pauli, S., Karlsson, P., Farde, L., Nordstrom, A.L., Nyberg, S., Halldin, C. (1995) PET imaging of neuroreceptors in schizophrenia. Eur. Neuropsychopharmcol. [Suppl.] 5:25-30.
41. Seeman, P., Van Tol, H.H. (1994) Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15:264-270.
42. Seeman, P., Bzowej, N.H., Guan, H.C., Bergeron, C., Becher, L.E., Reynolds, G.P., Bird, E.D., Riederer, P., Jellinger, K., Watanable, S., Tourtellotte, W.W. (1987) Human brain dopamine receptors in children and aging adults. Synapse 1:399-404.
43. Severson, J.A., Marcusson, J.O., Winblad, B., Finch, C.E. (1982) Age-correlated loss of dopaminergic binding sites in human basal ganglia. J. Neurochem. 39:1623-1631.
44. Shinotoh, H., Inoue, O., Hirayama, K., Aotsuka, A., Asahina, M., Suhara, T., Yamazaki, T., Tateno, Y. (1993) Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: A positron emission tomography study. J. Neurol. Neurosurg. Psychiatry 56: 467-472.
45. Sokoloff, P., Schwartz, J.C. (1995) Novel dopamine receptors half a decade later [review]. Trends Pharmacol. Sci. 16:270-275.
46. Suhara, T., Fukuda, H., Inoue, O., Itoh, T., Suzuki, K., Yamasaki, T., Tateno, Y. (1991) Age-related changes in human D1 dopamine receptors measured by positron emission tomograpy. Psychopharmacology (Berlin) 103:41-45.
47. 11C]SCH 23390. Identification of two radiolabelled metabolites with HPLC. Hum. Psychopharmacol. 9:25-31.
48. Turjanski, N., Weeks, R., Dolan, R., Harding, A.E., Brooks, D.J. (1995) Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study. Brain 118:689-696.
49. Vingerhoets, F.J., Snow, B.J., Schulzer, M., Morrison, S., Ruth, T.J., Holden, J.E., Cooper, S., Calne, D.B. (1994) Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects. J. Nucl. Med. 35:18-24.
50. Vingerhoets, F.J.G., Schulzer, M., Calne, D.B., Snow, B.J. (1997) Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion. Ann. Neurol. 41:58-64.
51. Wang, G.J., Volkow, N.D., Logan, J., Gowler, J.S., Schlyer, D., MacGregor, R.R., Hitzemann, R.J., Cur, R.C., Wolf, A.P. (1995) Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects. Life Sci. 56:249-253.
52. Wang, G.J., Volkow, N.D., Levy, A.V, Fowler, J.S., Logan, J., Alexoff, D., Hitzemann, R.J., Schyler, D.J. (1996) MR-PET image coregistration for quantitation of striatal dopamine D2 receptors. J. Comput. Assist. Tomogr. 20:423-428.